Effect of Vitamin C on pediatrics urinary tract infection

Assessment of complementary Vitamin C on pediatrics urinary tract infection

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015073113366N5

Enrollment

152

Registered

2017-02-19

Start date

2011-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection. Urinary tract infection, site not specified

Interventions

Intervention 1: Add vitamin C to common treatment of urinary tract infections. Intervention 2: Ceftriaxone at a dose of 50- 75 mg / kg / day / iv used in both intervention and control groups, which is

Treatment - Drugs

Add vitamin C to common treatment of urinary tract infections

Ceftriaxone at a dose of 50- 75 mg / kg / day / iv used in both intervention and control groups, which is in a period of 14 days.

Eligibility

Sex/Gender

Female

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the positive urinary tract infection; absence of congenital kidney disease and consent to participate in research project. Exclusion criteria: any reason patients want to leave the study and not satisfied to use their personal data in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urinary tract infection. Timepoint: Before and after drug consumption which is in a period of 14 days. Method of measurement: Urine culture.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026